Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2010
09/30/2010US20100247679 Methods and compositions for altering cell function
09/30/2010US20100247677 Compositions and Methods for Preferential Distribution of Active Agents to Injury Sites
09/30/2010US20100247661 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
09/30/2010US20100247653 Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
09/30/2010US20100247645 Pharmaceutical combination of aliskiren and valsartan
09/30/2010US20100247619 Nanostructured Lipid Carriers Containing Riluzole And Phamaceutical Formulations Containing Said Particles
09/30/2010US20100247617 Transdermal Administration Of (2S)-(4E)-N-Methyl-5-(3-(5-Isopropoxypyridin)yl)-4-Penten-2-Amine
09/30/2010US20100247610 Gastric retained gabapentin dosage form
09/30/2010US20100247586 Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
09/30/2010US20100247583 Novel n-phenylacetamide inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
09/30/2010US20100247552 Pak modulators
09/30/2010US20100247543 Treatment and prevention of neurodegenerative diseases
09/30/2010US20100247534 Fused heterocyclic compounds as inhibitors of potassium channel function
09/30/2010US20100247530 Compositions and methods for preventing and treating presbycusis
09/30/2010US20100247519 Heterocyclic aspartyl protease inhibitors
09/30/2010US20100247518 Modified proteins, designer toxins, and methods of making thereof
09/30/2010US20100247517 Use of mnk inhibitors for the treatment of alzheimer's disease
09/30/2010US20100247514 Gamma secretase modulators
09/30/2010US20100247511 Methods and compositions for activated protein c with reduced anticoagulant properties
09/30/2010US20100247506 Formation of stable submicron peptide or protein particles by thin film freezing
09/30/2010US20100247499 hUTC AS THERAPY FOR ALZHEIMER'S DISEASE
09/30/2010US20100247496 Neuronal viability factor and use thereof
09/30/2010US20100247483 Therapeutic agent composition and method of use
09/30/2010US20100247463 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
09/30/2010US20100247439 Dendritic nano-antioxidants
09/30/2010CA2756750A1 A method for producing bicyclic .gamma.-amino acid derivative
09/30/2010CA2756670A1 Mesenchymal stem cells producing inhibitory rna for disease modification
09/30/2010CA2756645A1 Therapeutic uses of quinazolinedione derivatives
09/30/2010CA2756600A1 Human umbilical cord tissue cells as therapy for alzheimer's disease
09/30/2010CA2756518A1 Fused pyrimidinedione derivatives as trpa1 modulators
09/30/2010CA2756178A1 Compounds as cannabinoid receptor ligands
09/30/2010CA2756107A1 Composition for regulating autonomic nervous activity and method for regulating autonomic nerve
09/30/2010CA2755680A1 P2x3, receptor antagonists for treatment of pain
09/30/2010CA2754416A1 Novel medicament for treating cognitive impairment
09/30/2010CA2753868A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/30/2010CA2660962A1 Novel pharmaceutical composition for treatment of schizophrenia
09/29/2010EP2233487A1 Spirocyclic cyclohexane derivatives
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2233474A1 Condensed aminodihydrothiazine derivative
09/29/2010EP2233471A1 A salt of 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-quinolinone with 5-sulfosalicylic acid and its preparation process
09/29/2010EP2233465A1 Preparation method of rivastigmine, its intermediates and preparation method of the intermediates
09/29/2010EP2233155A2 Therapeutic polyanhydride compounds for drug delivery
09/29/2010EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone
09/29/2010EP2233140A1 Bicyclic amides for enhancing glutamatergic synaptic responses
09/29/2010EP2233136A1 Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
09/29/2010EP2231672A1 Biaryl substituted diazabicycloalkane derivatives
09/29/2010EP2231671A1 Modulators of cystic fibrosis transmembrane conductance regulator
09/29/2010EP2231659A1 Translocator protein ligands
09/29/2010EP2231657A1 Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
09/29/2010EP2231655A2 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl)benzenesulfonamide derivati ves and related compounds as modulators of ion channels for the treatment of pain
09/29/2010EP2231651A1 Isoxazolo-pyridazine derivatives
09/29/2010EP2231645A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231644A2 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231643A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/29/2010EP2231630A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl]cyclobut anecarboxamide
09/29/2010EP2231629A1 Modulators for amyloid beta
09/29/2010EP2231618A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use
09/29/2010EP2231602A1 Gamma secretase modulators
09/29/2010EP2231601A2 Glycine transporter-1 inhibitors
09/29/2010EP2231599A1 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
09/29/2010EP2231594A2 Potassium ion channel modulators and uses thereof
09/29/2010EP2231558A1 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
09/29/2010EP2231154A1 Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter
09/29/2010EP2231153A2 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators
09/29/2010EP2231150A2 Method for treating addiction using quercetin-containing compositions
09/29/2010EP2231149A2 Aldh-2 inhibitors in the treatment of psychiatric disorders
09/29/2010EP2231137A1 Method of modulating membrane potential of a cell
09/29/2010EP2230933A1 5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphtalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde used as drugs
09/29/2010EP1917265B1 HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF
09/29/2010EP1893200B1 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
09/29/2010EP1789398B1 2-amino-quinazoline derivatives useful as inhibitors of b-secretase (bace)
09/29/2010EP1768979B1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof
09/29/2010EP1617852B1 Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration
09/29/2010EP1578412B1 Pharmaceutical compositions and method of treating parkinson's disease
09/29/2010EP1421074B1 Novel compounds
09/29/2010CN1990036B Paraplegia treating Chinese traditional medicine
09/29/2010CN1972938B 环状胺化合物 Cyclic amine compound
09/29/2010CN1899287B Slow release medicinal composition for treating anxiety and its preparing method
09/29/2010CN1893963B Production of hop extracts having oestrogenic and antiproliferative bioactivity
09/29/2010CN1872037B Drop pills of paeonol, and preparation method
09/29/2010CN1832734B Substituted 2-amino-1,2,3,4-tetrahydronaphthalene of depression
09/29/2010CN1788609B Preparation method of gastrodia tuber essence serial health product
09/29/2010CN1753673B Prodrugs of GABA analogs, compositions and uses thereof
09/29/2010CN1475207B Solid oral dosage mode containing walshaden and hydrochloric thizaine
09/29/2010CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof
09/29/2010CN101848934A Neuroprotection using NAP-like and SAL-like peptide mimetics
09/29/2010CN101848910A 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
09/29/2010CN101848909A Pyrrolo(3,2-C) pyridines useful as inhibitors of protein kinases
09/29/2010CN101848907A Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibition
09/29/2010CN101848903A Piperazine derivative having affinity for the histamine H3 receptor
09/29/2010CN101848893A 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
09/29/2010CN101848735A Novel neurturin conjugates for pharmaceutical use
09/29/2010CN101848726A Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
09/29/2010CN101848725A 组合物 The composition
09/29/2010CN101848713A Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
09/29/2010CN101848712A Treatment of progressive neurodegenerative disease with ibudilast
09/29/2010CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
09/29/2010CN101845416A Adipose-derived stem cell for senile dementia treatment
09/29/2010CN101845099A Long-acting analgesic peptide and application thereof
09/29/2010CN101845093A Purification method for large-scale production of nerve growth factors in cobra venin
1 ... 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 ... 1833